Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.

Autor: Dummer R; Department of Dermatology, Skin Cancer Center, University Hospital Zurich, Zurich, Switzerland. Electronic address: reinhard.dummer@usz.ch., Queirolo P; IRCCS Istituto Europeo di Oncologia, Milan, Italy., Abajo Guijarro AM; F Hoffman-La Roche, Basel, Switzerland., Hu Y; F Hoffman-La Roche, Basel, Switzerland., Wang D; F Hoffman-La Roche, Basel, Switzerland., de Azevedo SJ; Hospital de Clínicas de Porto Alegre, Unidade de Pesquisa Clinica em Oncologia, Porto Alegre, Brazil., Robert C; Gustave Roussy and Université Paris-Saclay, Villejuif-Paris, France., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione 'G Pascale,' Naples, Italy., Chiarion-Sileni V; Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy., Pronzato P; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Genova, Italy., Mujika Eizmendi K; Onkologikoa Hospital, Donostia, Spain., Liszkay G; Országos Onkológiai Intézet, Budapest, Hungary., de la Cruz Merino L; Hospital Universitario Virgen Macarena, Clinical Oncology Department and Medicine Department, University of Seville, Seville, Spain., Tawbi H; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Sep; Vol. 23 (9), pp. 1145-1155. Date of Electronic Publication: 2022 Aug 05.

Mélanome : avancées et perspectives.

Autor: Monestier, Sandrine¹ Sandrine.MONESTIER@ap-hm.fr

Publikováno v: Dermato Mag. 2023 Supplement 6, Vol. 11, p26-31. 6p.

The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study

Autor: Dummer, Reinhard^1,2 (AUTHOR) reinhard.dummer@usz.ch, Welti, Michèle^1,2 (AUTHOR), Ramelyte, Egle^1,2 (AUTHOR)

Publikováno v: Journal of Translational Medicine. 8/5/2023, Vol. 21 Issue 1, p1-5. 5p.

Management of melanoma central nervous system metastases.

Autor: Rutkowski, Piotr, Kiprian, Dorota, Świtaj, Tomasz, Michalik, Radosław, Spałek, Mateusz, Kozak, Katarzyna, Mandat, Tomasz, Cybulska-Stopa, Bożena, Dudzisz-Śledź, Monika

Publikováno v: Oncology in Clinical Practice (2450-1654); 2024, Vol. 20 Issue 3, p161-174, 14p

Effectiveness, safety and utilization of cobimetinib and vemurafenib in patients with BRAF V600 mutant melanoma with and without cerebral metastasis under real-world conditions in Germany: the non-interventional study coveNIS.

Autor: Kähler, Katharina C., Debus, Dirk, Schley, Gaston, Göppner, Daniela, Hassel, Jessica C., Meier, Friedegund, Terheyden, Patrick, Stadler, Rudolf, Tüting, Thomas, Kaatz, Martin, Hoff, Norman-Philipp, Masoudi, Ehsan, Zdanowicz-Specht, Agnieszka, Nguyen, Minh Tam, Mohr, Peter

Publikováno v: Melanoma Research; Feb2024, Vol. 34 Issue 1, p44-53, 10p